Clinical Trial Update: A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SI-B003, BL-B01D1+SI-B003, and BL-B01D1+PD-1 monoclonal antibody in locally advanced or metastatic esophageal cancer, gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• BL-B01D1
• PD-1 monoclonal antibody
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: RECRUITING